Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities

David A. Sallman, John Barnard, Najla H. Al Ali, Guillermo Garcia-Manero, Mikkael A. Sekeres, Amy DeZern, David P. Steensma, Gail Roboz, Elias Jabbour, Jaroslaw P. Maciejewski, Sherry Pierce, Eric Padron, Jeffrey E. Lancet, Hagop Kantarjian, Alan F. List, Rami S. Komrokji

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities'. Together they form a unique fingerprint.

Medicine & Life Sciences